AKT1 and cancer: CD146 activated RhoA leads to increased RhoA activity and migration of the melanoma cells through the activation of the PIP5Ks/AKT pathway, a lipid kinase which plays a role in cancer cell evasion and cell survival through the PI3K/AKT pathway [66,67].